$25.75
+0.68 (+2.71%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+163.56%
YTD
+23.68%
Open$25.17
Previous Close$25.07
Day High$25.81
Day Low$25.09
52W High$30.06
52W Low$8.93
Volume—
Avg Volume868.0K
Market Cap2.72B
P/E Ratio—
EPS$-2.51
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$22.49
Above
SMA 200
$14.32
Above
RSI (14)
37.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+410.6% upside
Current
$25.75
$25.75
Target
$131.49
$131.49
$82.08
$131.49 avg
$141.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.10M | 603.96M | 550.96M |
| Net Income | -278,257,031 | -173,219,826 | -162,867,502 |
| Profit Margin | -3,060.0% | -28.7% | -29.6% |
| EBITDA | -290,376,060 | -273,358,868 | -247,027,649 |
| Free Cash Flow | — | -130,399,233 | -192,377,550 |
| Rev Growth | — | +13.0% | +19.7% |
| Debt/Equity | — | 0.20 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |